The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers

Breast Cancer Research and Treatment

Volumn 137, Issue 1, 2013, Pages 315-318

  Mazzola, Emanuele ^a   Cheng, Su Chun ^a   Parmigiani, Giovanni ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Age specific risk; BRCA1; BRCA2; Ductal carcinoma in situ; Lifetime risk; Mutation carrier; Penetrance function

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; DISEASE CARRIER; FEMALE; GENE MUTATION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BAYES THEOREM; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MODELS, GENETIC; MUTATION; PENETRANCE; RETROSPECTIVE STUDIES; RISK; SEER PROGRAM; YOUNG ADULT;

EID: 84871733286     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2345-5     Document Type: Article

References (15)

1. Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401-1408
2. Ford D, Easton DF, Bishop DT et al (1994) Breast Cancer Linkage Consortium: risks of cancer in BRCA1 mutation carriers. Lancet 343(8899):692-695
3. Easton DF, Ford D (1995) Bishop DT Breast and ovarian cancer incidence in BRCA1 mutation carriers: Breast Linkage Consortium. Am J Hum Genet 56(1):265-271
4. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: the Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676-689
5. Thorlacius S, Struewing JP, Hartge P et al (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337-1339
6. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Sci Agric 302:643-646
7. Begg CB, Haile RW, Borg A et al (2008) Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299(2):194-201
8. Claus EB, Petruzella S, Matloff E et al (2005) Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA 293(8):964-969
9. Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480-1490
10. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329-1333
11. Parmigiani G, Berry DA, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145-158
12. Antoniou AC, Pharoah PP, Smith P et al (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91:1580-1590
13. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130
14. Altekruse SF, Kosary CL, Krapcho M et al (2010) SEER cancer statistics review, 1975-2007. NCI, Bethesda
15. Cheng S, Wang W, Broman KW et al (2004) BayesMendel: an R environment for Mendelian risk prediction. Stat Appl Genet Mol Biol 3(1):article 21